Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127253831 | 12725383 | 1 | I | 20160824 | 20160908 | 20160908 | EXP | CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL002575 | VALIDUS | REIMCHE R., SALCEDO D.,. CANADIAN PALLIATIVE COMMUNITY MILRINONE INFUSIONS: A CASE SERIES. CAN J CARDIOVASC NURS. 2016;26(1):9-13 | 73.00 | YR | M | Y | 0.00000 | 20160908 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127253831 | 12725383 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | U | 16273 | ||||||||||
| 127253831 | 12725383 | 2 | SS | FUROSEMIDE. | FUROSEMIDE | 1 | 100 MG, BID | U | 16273 | 100 | MG | ||||||||
| 127253831 | 12725383 | 3 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | UNK | U | 0 | ||||||||||
| 127253831 | 12725383 | 4 | C | ALLOPURINOL. | ALLOPURINOL | 1 | UNK | U | 0 | ||||||||||
| 127253831 | 12725383 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | UNK | U | 0 | ||||||||||
| 127253831 | 12725383 | 6 | C | CARVEDILOL. | CARVEDILOL | 1 | UNK | U | 0 | ||||||||||
| 127253831 | 12725383 | 7 | C | HYDRALAZINE | HYDRALAZINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 127253831 | 12725383 | 8 | C | ISOSORBIDE MONONITRATE. | ISOSORBIDE MONONITRATE | 1 | UNK | U | 0 | ||||||||||
| 127253831 | 12725383 | 9 | C | INSULIN GLARGINE | INSULIN GLARGINE | 1 | UNK | U | 0 | ||||||||||
| 127253831 | 12725383 | 10 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | UNK | U | 0 | ||||||||||
| 127253831 | 12725383 | 11 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 127253831 | 12725383 | 12 | C | SALBUTAMOL | ALBUTEROL | 1 | UNK | U | 0 | ||||||||||
| 127253831 | 12725383 | 13 | C | WARFARIN | WARFARIN | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127253831 | 12725383 | 1 | Product used for unknown indication |
| 127253831 | 12725383 | 3 | Product used for unknown indication |
| 127253831 | 12725383 | 4 | Product used for unknown indication |
| 127253831 | 12725383 | 5 | Product used for unknown indication |
| 127253831 | 12725383 | 6 | Product used for unknown indication |
| 127253831 | 12725383 | 7 | Product used for unknown indication |
| 127253831 | 12725383 | 8 | Product used for unknown indication |
| 127253831 | 12725383 | 9 | Product used for unknown indication |
| 127253831 | 12725383 | 10 | Product used for unknown indication |
| 127253831 | 12725383 | 11 | Product used for unknown indication |
| 127253831 | 12725383 | 12 | Product used for unknown indication |
| 127253831 | 12725383 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127253831 | 12725383 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127253831 | 12725383 | Ascites | |
| 127253831 | 12725383 | Blood creatinine increased | |
| 127253831 | 12725383 | Drug ineffective | |
| 127253831 | 12725383 | Dyspnoea | |
| 127253831 | 12725383 | Weight increased | |
| 127253831 | 12725383 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |